29–30 Sep 2027 · Basel, CH

Drug Discovery Innovation Programme EU 2026

Drug Discovery Innovation Programme (DDIP) Europe 2026 is a two-day B2B conference held September 29–30, 2026 at the Movenpick Hotel Basel, bringing together senior leaders from pharma, biotech, academia, and technology providers to discuss advances in drug discovery. The programme covers topics including AI, translational science, biologics, computational approaches, and emerging therapeutic modalities, and is organized as a focused event for decision makers with curated content, case studies and networking.

Last updated

Dates
29–30 Sep 2027
Venue
Movenpick Hotel Basel
Location
Basel, CH
Frequency
Annual
Audience
Trade
Duration
2 days
Scale
International
Visitors
100Fact
Pharma & BiotechChemicals & MaterialsHealthcare & Medical

Compiled from public sources and periodically reviewed and updated. This information is provided for general guidance only and may be incomplete or out of date — please verify all details directly with the organizer or venue before relying on them.

About Drug Discovery Innovation Programme EU 2026

Drug Discovery Innovation Programme EU 2026 is an international trade show in Basel, Switzerland for the Pharma & Biotech and Chemicals & Materials industries. The 2027 edition runs 29–30 Sep 2027 at Movenpick Hotel Basel. It brings together 100 visitors (organizer-confirmed).

Known editions

Venue

Movenpick Hotel Basel

Messeplatz, CH-4021 Basel, 4058 Basel, Basel-City, CH

Exhibitors

We haven't indexed the exhibitors for this event yet. We add them as events are confirmed and rosters are published — please check back soon.

Related events

More Pharma & Biotech in Switzerland →

Frequently asked questions

When is Drug Discovery Innovation Programme EU 2026 2027?
Drug Discovery Innovation Programme EU 2026 2027 runs 29–30 Sep 2027 at Movenpick Hotel Basel.
Where is Drug Discovery Innovation Programme EU 2026 held?
Drug Discovery Innovation Programme EU 2026 is held at Movenpick Hotel Basel in Basel, Switzerland.
Is Drug Discovery Innovation Programme EU 2026 worth attending?
Drug Discovery Innovation Programme EU 2026 is an international trade show for the Pharma & Biotech and Chemicals & Materials industries, so it is most relevant to exhibitors and buyers in those industries. Whether it is worth attending depends on your objectives, but its scale and sector focus are a useful guide.

The data on this page comes from Pragmatic Event Scout — a live catalog of 14,000+ trade shows where every figure is labeled as a fact or an estimate.Logos provided by Logo.dev

See the full exhibitor list

Every exhibitor, every event, searchable — with CSV & calendar export.

7 days free, then $23/month